Gensight Biologics SA
PAR:SIGHT

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
PAR:SIGHT
Watchlist
Price: 0.277 EUR -2.46% Market Closed
Market Cap: 32.6m EUR

Gensight Biologics SA
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Gensight Biologics SA
Other Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Gensight Biologics SA
PAR:SIGHT
Other Liabilities
€6.9m
CAGR 3-Years
27%
CAGR 5-Years
138%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Other Liabilities
€7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innate Pharma SA
PAR:IPH
Other Liabilities
€6.9m
CAGR 3-Years
-40%
CAGR 5-Years
-36%
CAGR 10-Years
15%
G
Genfit SA
PAR:GNFT
Other Liabilities
€1m
CAGR 3-Years
-40%
CAGR 5-Years
-26%
CAGR 10-Years
-13%
Inventiva SA
PAR:IVA
Other Liabilities
€23.5m
CAGR 3-Years
85%
CAGR 5-Years
51%
CAGR 10-Years
N/A
Eurobio Scientific SA
PAR:ALERS
Other Liabilities
€1.9m
CAGR 3-Years
-15%
CAGR 5-Years
-6%
CAGR 10-Years
0%

Gensight Biologics SA
Glance View

Market Cap
32.6m EUR
Industry
Biotechnology

GenSight Biologics SA is a clinical-stage gene therapy company. The company is headquartered in Paris, Ile-De-France. The company went IPO on 2016-07-13. The firm develops and commercializes gene therapy-based treatments of retinal degenerative diseases. The company develops approaches to prevent retinal degeneration in selected pathological conditions and to restore vision in patients suffering from low vision or blindness. The firm intends notably to develop a gene replacement therapy for Leber's hereditary optic neuropathy (LHON) and an optogenetic therapy for retinitis pigmentosa (RP).

SIGHT Intrinsic Value
0.163 EUR
Overvaluation 41%
Intrinsic Value
Price

See Also

What is Gensight Biologics SA's Other Liabilities?
Other Liabilities
6.9m EUR

Based on the financial report for Jun 30, 2024, Gensight Biologics SA's Other Liabilities amounts to 6.9m EUR.

What is Gensight Biologics SA's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
138%

Over the last year, the Other Liabilities growth was -4%. The average annual Other Liabilities growth rates for Gensight Biologics SA have been 27% over the past three years , 138% over the past five years .

Back to Top